InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.00%
)
US TECH 100
17,740.80
(
0.33%
)
Dow Jones
39,512.84
(
0.00%
)
Brent Oil
83.11
(
0.87%
)
Bitcoin
62,823.21
(
2.24%
)
Post# of 2020
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Work Harder

Send PM Follow Ignore
Followers 101
Posts 13186
Boards Moderated 0
Alias Born 06/01/2013

Work Harder

Re: bow-tie post# 1773

Saturday, 12/16/2017 3:42:10 PM

Saturday, December 16, 2017 3:42:10 PM

Post# of 2020
This is CB24

The therapeutic response obtained in some patients is quite promising and deserves additional development of this compound under a Phase II clinical trial. The recommended dose for Phase II studies is 0.18 mg/m2.

http://clincancerres.aacrjournals.org/content/8/4/1033.full
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up